1. Home
  2. HRMY vs NFE Comparison

HRMY vs NFE Comparison

Compare HRMY & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • NFE
  • Stock Information
  • Founded
  • HRMY 2017
  • NFE 2014
  • Country
  • HRMY United States
  • NFE United States
  • Employees
  • HRMY N/A
  • NFE N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • NFE Oil/Gas Transmission
  • Sector
  • HRMY Health Care
  • NFE Utilities
  • Exchange
  • HRMY Nasdaq
  • NFE Nasdaq
  • Market Cap
  • HRMY 2.1B
  • NFE 2.4B
  • IPO Year
  • HRMY 2020
  • NFE 2019
  • Fundamental
  • Price
  • HRMY $33.22
  • NFE $8.56
  • Analyst Decision
  • HRMY Buy
  • NFE Buy
  • Analyst Count
  • HRMY 9
  • NFE 6
  • Target Price
  • HRMY $47.00
  • NFE $22.00
  • AVG Volume (30 Days)
  • HRMY 1.3M
  • NFE 5.4M
  • Earning Date
  • HRMY 10-29-2024
  • NFE 11-07-2024
  • Dividend Yield
  • HRMY N/A
  • NFE 4.67%
  • EPS Growth
  • HRMY N/A
  • NFE N/A
  • EPS
  • HRMY 2.11
  • NFE 0.91
  • Revenue
  • HRMY $681,879,000.00
  • NFE $2,417,879,000.00
  • Revenue This Year
  • HRMY $24.63
  • NFE N/A
  • Revenue Next Year
  • HRMY $18.04
  • NFE $31.74
  • P/E Ratio
  • HRMY $15.77
  • NFE $9.46
  • Revenue Growth
  • HRMY 25.83
  • NFE 11.58
  • 52 Week Low
  • HRMY $26.03
  • NFE $7.82
  • 52 Week High
  • HRMY $41.61
  • NFE $40.04
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 44.15
  • NFE 44.09
  • Support Level
  • HRMY $32.37
  • NFE $8.68
  • Resistance Level
  • HRMY $36.68
  • NFE $9.84
  • Average True Range (ATR)
  • HRMY 2.02
  • NFE 0.67
  • MACD
  • HRMY -0.07
  • NFE 0.08
  • Stochastic Oscillator
  • HRMY 20.73
  • NFE 32.60

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About NFE New Fortress Energy Inc.

New Fortress Energy is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to both lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include terminals and infrastructure, or T&I, and ships.

Share on Social Networks: